Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
The primary objective of this study was to determine the proportion of subjects, seronegative to all three strains of influenza, as defined by a serum hemagglutination inhibition antibodies (HAI) antibody titer of \<1:10, who shed each vaccine virus strain following a single dose of CAIV-T.
Epistemonikos ID: c89332b82a2bb8a8ac944398d60b3c5941f57837
First added on: Mar 23, 2020